← Leaderboards
Ben Shen
University Of California Davis
$24,533,795
Attributed
$28,845,052
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,213,152 · 17
By mechanism
R01$20,681,161 · 8
U19$6,587,938 · 2
R35$4,267,027 · 1
P41$1,113,585 · 1
K02$534,600 · 1
R21$474,937 · 1
Top collaborators
- Christoph Rader6 shared
- Ya-Ming Hou5 shared
- Michael A. Kron2 shared
- Natarajan Muthusamy1 shared
Others in their field
Top investigators on “Anabolism”
- David R Andes · University Of Wisconsin Madison$30,140,339
- Robert Schwarcz · University Of Maryland Baltimore$22,941,075
- Margaret A. Phillips · Ut Southwestern Medical Center$18,854,558
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$18,572,826
- Sean F Brady · Rockefeller University$15,078,958
- Edward I Solomon · Stanford University$15,055,107
Research focus
AnabolismProductionDrug DiscoveryEngineeringPharmaceutical PreparationsMolecularAnalogGrantGenetic ManipulationIn VivoStreptomycesComplexGene ClusterBaseChemistryMicrobialPathway InteractionsBiochemicalEnzymatic BiochemistryScaffoldMemberMicroorganismIn VitroFamily
Grant awards (86)
TrmD-targeting actinobacterial natural products as next generation antibiotics$1,179,849
R01 · FY2025 · AI
Mining Actinobacterial Genomes for Natural Product Discovery and Biosynthesis$850,080
R35 · FY2025 · GM · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$685,157
R01 · FY2025 · CA · contact PI
Mining Actinobacterial Genomes for Natural Product Discovery and Biosynthesis$880,587
R35 · FY2024 · GM · contact PI
TrmD-targeting actinobacterial natural products as next generation antibiotics$483,241
R01 · FY2024 · AI
TrmD-targeting actinobacterial natural products as next generation antibiotics$847,145
R01 · FY2023 · AI
TrmD-targeting actinobacterial natural products as next generation antibiotics$831,545
R01 · FY2022 · AI
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis$603,302
R35 · FY2022 · GM · contact PI
A Drug Delivery Strategy for Targeted Therapy of Chronic Lymphocytic Leukemia$563,511
R01 · FY2022 · CA · contact PI
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis$192,054
R35 · FY2022 · GM · contact PI
TrmD-targeting actinobacterial natural products as next generation antibiotics$845,545
R01 · FY2021 · AI
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis$795,502
R35 · FY2021 · GM · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$535,980
R01 · FY2021 · CA · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$122,993
R01 · FY2021 · CA · contact PI
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis$795,502
R35 · FY2020 · GM · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$658,973
R01 · FY2020 · CA · contact PI
Mining Actinomycetal Genomes for Natural Product Discovery and Biosynthesis$150,000
R35 · FY2020 · GM · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$639,203
R01 · FY2019 · CA · contact PI
Genome Mining for Enediyne Natural Products from Actinomycetals$479,999
R01 · FY2019 · GM · contact PI
Discovery and biosynthesis of diterpenoid natural products in actinomycetals$458,880
R01 · FY2019 · GM · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$658,973
R01 · FY2018 · CA · contact PI
Genome Mining for Enediyne Natural Products from Actinomycetals$479,999
R01 · FY2018 · GM · contact PI
Discovery and biosynthesis of diterpenoid natural products in actinomycetals$458,880
R01 · FY2018 · GM · contact PI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers$658,973
R01 · FY2017 · CA · contact PI
Genome Mining for Enediyne Natural Products from Actinomycetals$479,999
R01 · FY2017 · GM · contact PI
Discovery and biosynthesis of diterpenoid natural products in actinomycetals$458,880
R01 · FY2017 · GM · contact PI
Genome Mining for Enediyne Natural Products from Actinomycetals$480,002
R01 · FY2016 · GM · contact PI
Discovery and biosynthesis of diterpenoid natural products in actinomycetals$458,880
R01 · FY2016 · GM · contact PI
Enediyne Biosynthesis and Engineering$410,850
R01 · FY2015 · CA · contact PI
AT-less Type I Polyketide Synthases$384,868
R01 · FY2015 · CA · contact PI
Enediyne Biosynthesis and Engineering$398,525
R01 · FY2014 · CA · contact PI
AT-less Type I Polyketide Synthases$373,322
R01 · FY2014 · CA · contact PI
Natural products as antifilarial asparaginyl-tRNA synthetase inhibitors$256,516
R21 · FY2014 · AI
Enediyne Biosynthesis and Engineering$386,199
R01 · FY2013 · CA · contact PI
AT-less Type I Polyketide Synthases$361,776
R01 · FY2013 · CA · contact PI
Natural products as antifilarial asparaginyl-tRNA synthetase inhibitors$218,421
R21 · FY2013 · AI
Enediyne Biosynthesis and Engineering$410,850
R01 · FY2012 · CA · contact PI
AT-less Type I Polyketide Synthases$384,868
R01 · FY2012 · CA · contact PI
Natural Products from Under-explored Microorganisms$371,195
P41 · FY2012 · GM · contact PI
Enediyne Biosynthesis and Engineering$410,850
R01 · FY2011 · CA · contact PI
AT-less Type I Polyketide Synthases$384,868
R01 · FY2011 · CA · contact PI
Natural Products from Under-explored Microorganisms$371,195
P41 · FY2011 · GM · contact PI
Natural Products from Under-explored Microorganisms$371,195
P41 · FY2010 · GM · contact PI
Platnesimycin and platencin biosynthesis and engineering in antibacterial drugs$348,640
R56 · FY2010 · AI · contact PI
Platnesimycin and platencin biosynthesis and engineering in antibacterial drugs$14,850
R56 · FY2010 · AI · contact PI
UWCCC National Cooperative Drug Discovery Group for Can*$1,038,617
U19 · FY2009 · CA · contact PI
Diversifying Natural Products via Combinatorial Biosynthesis Methods$279,516
U19 · FY2009 · CA · contact PI
Enediyne Biosynthesis and Engineering$178,357
R01 · FY2009 · CA · contact PI
Enediyne Biosynthesis and Engineering$135,759
R01 · FY2009 · CA · contact PI
UWCCC National Cooperative Drug Discovery Group for Can*$1,044,616
U19 · FY2008 · CA · contact PI
AT-less Type I Polyketide Synthases$281,051
R01 · FY2008 · CA · contact PI
Diversifying Natural Products via Combinatorial Biosynthesis Methods$274,657
U19 · FY2008 · CA · contact PI
Enediyne Biosynthesis and Engineering$135,824
R01 · FY2008 · CA · contact PI
UWCCC National Cooperative Drug Discovery Group for Can*$25,000
U19 · FY2008 · CA · contact PI
7th US-Japan Seminar on Biosyntyhesis of Natural Products 6/22-26/2008$9,000
R13 · FY2008 · GM · contact PI
UWCCC National Cooperative Drug Discovery Group for Can*$1,052,474
U19 · FY2007 · CA · contact PI
Biosynthesis of hybrid peptide-polyketide antibiotics$291,787
R01 · FY2007 · CA · contact PI
AT-less Type I Polyketide Synthases$281,102
R01 · FY2007 · CA · contact PI
Diversifying Natural Products via Combinatorial Biosynthesis Methods$275,075
U19 · FY2007 · CA · contact PI
Enediyne Biosynthesis and Engineering$135,886
R01 · FY2007 · CA · contact PI
UWCCC National Cooperative Drug Discovery Group for Can*$1,101,149
U19 · FY2006 · CA · contact PI
Biosynthesis of hybrid peptide-polyketide antibiotics$300,501
R01 · FY2006 · CA · contact PI
"AT-less" Type I Polyketide Synthases$289,548
R01 · FY2006 · CA · contact PI
Diversifying Natural Products via Combinatorial Biosynthesis Methods$180,209
U19 · FY2006 · CA · contact PI
Enediyne Biosynthesis and Engineering$140,007
R01 · FY2006 · CA · contact PI
UWCCC National Cooperative Drug Discovery Group for Cancer$1,106,244
U19 · FY2005 · CA
Biosynthesis of hybrid peptide-polyketide antibiotics$307,733
R01 · FY2005 · CA
"AT-less" Type I Polyketide Synthases$296,568
R01 · FY2005 · CA
Diversifying Natural Products via Combinatorial Biosynthesis Methods$210,381
U19 · FY2005 · CA
Enediyne Biosynthesis and Engineering$143,438
R01 · FY2005 · CA
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes$106,920
K02 · FY2005 · AI
Biosynthesis of hybrid peptide-polyketide antibiotics$307,733
R01 · FY2004 · CA
"AT-less" Type I Polyketide Synthases$296,617
R01 · FY2004 · CA
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes$106,920
K02 · FY2004 · AI
Biosynthesis of hybrid peptide-polyketide antibiotics$307,733
R01 · FY2003 · CA
ENEDIYNE ANTITUMOR ANTIBIOTIC BIOSYNTHESIS$113,951
R01 · FY2003 · CA
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes$106,920
K02 · FY2003 · AI
ENEDIYNE ANTITUMOR ANTIBIOTIC BIOSYNTHESIS$110,631
R01 · FY2002 · CA
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes$106,920
K02 · FY2002 · AI
ENEDIYNE ANTITUMOR ANTIBIOTIC BIOSYNTHESIS$107,410
R01 · FY2001 · CA
Enediyne Antitumor Antibiotic Synthesis - Streptomycetes$106,920
K02 · FY2001 · AI
ENEDIYNE ANTITUMOR ANTIBIOTIC BIOSYNTHESIS$43,220
R01 · FY2001 · CA
BIOSYNTHESIS OF PEPTIDE/POLYKETIDE DERIVED ANTIBIOTICS$42,100
R29 · FY2001 · AI
BIOSYNTHESIS OF PEPTIDE/POLYKETIDE DERIVED ANTIBIOTICS$37,651
R29 · FY2001 · AI
ENEDIYNE ANTITUMOR ANTIBIOTIC BIOSYNTHESIS$102,722
R01 · FY2000 · CA
BIOSYNTHESIS OF PEPTIDE/POLYKETIDE DERIVED ANTIBIOTICS$101,663
R29 · FY2000 · AI